231 related articles for article (PubMed ID: 14724685)
1. Osteoarthritis gene therapy.
Evans CH; Gouze JN; Gouze E; Robbins PD; Ghivizzani SC
Gene Ther; 2004 Feb; 11(4):379-89. PubMed ID: 14724685
[TBL] [Abstract][Full Text] [Related]
2. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10.
Zhang X; Mao Z; Yu C
J Orthop Res; 2004 Jul; 22(4):742-50. PubMed ID: 15183429
[TBL] [Abstract][Full Text] [Related]
3. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis.
Kim SH; Lechman ER; Kim S; Nash J; Oligino TJ; Robbins PD
Mol Ther; 2002 Nov; 6(5):591-600. PubMed ID: 12409257
[TBL] [Abstract][Full Text] [Related]
5. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy.
Nixon AJ; Haupt JL; Frisbie DD; Morisset SS; McIlwraith CW; Robbins PD; Evans CH; Ghivizzani S
Gene Ther; 2005 Jan; 12(2):177-86. PubMed ID: 15578043
[TBL] [Abstract][Full Text] [Related]
6. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene.
Frisbie DD; Ghivizzani SC; Robbins PD; Evans CH; McIlwraith CW
Gene Ther; 2002 Jan; 9(1):12-20. PubMed ID: 11850718
[TBL] [Abstract][Full Text] [Related]
7. [Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy].
Guo WS; Ma L; Li ZR
Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):853-6. PubMed ID: 15200893
[TBL] [Abstract][Full Text] [Related]
8. Technology evaluation: MFG-IRAP, University of Pittsburgh.
Baragi VM
Curr Opin Mol Ther; 2000 Apr; 2(2):216-20. PubMed ID: 11249645
[TBL] [Abstract][Full Text] [Related]
9. Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium.
Hung GL; Galea-Lauri J; Mueller GM; Georgescu HI; Larkin LA; Suchanek MK; Tindal MH; Robbins PD; Evans CH
Gene Ther; 1994 Jan; 1(1):64-9. PubMed ID: 7584062
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway.
Neumann E; Judex M; Kullmann F; Grifka J; Robbins PD; Pap T; Gay RE; Evans CH; Gay S; Schölmerich J; Müller-Ladner U
Gene Ther; 2002 Nov; 9(22):1508-19. PubMed ID: 12407423
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-1 receptor antagonist and its delivery by gene transfer.
Evans CH; Robbins PD
Receptor; 1994; 4(1):9-15. PubMed ID: 8038709
[TBL] [Abstract][Full Text] [Related]
13. Gene therapeutic approaches-transfer in vivo.
Evans CH; Gouze E; Gouze JN; Robbins PD; Ghivizzani SC
Adv Drug Deliv Rev; 2006 May; 58(2):243-58. PubMed ID: 16563557
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model.
Watson Levings RS; Broome TA; Smith AD; Rice BL; Gibbs EP; Myara DA; Hyddmark EV; Nasri E; Zarezadeh A; Levings PP; Lu Y; White ME; Dacanay EA; Foremny GB; Evans CH; Morton AJ; Winter M; Dark MJ; Nickerson DM; Colahan PT; Ghivizzani SC
Hum Gene Ther Clin Dev; 2018 Jun; 29(2):90-100. PubMed ID: 29869540
[TBL] [Abstract][Full Text] [Related]
15. Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model.
Haupt JL; Frisbie DD; McIlwraith CW; Robbins PD; Ghivizzani S; Evans CH; Nixon AJ
J Orthop Res; 2005 Jan; 23(1):118-26. PubMed ID: 15607883
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis.
Yang SY; Wu B; Mayton L; Mukherjee P; Robbins PD; Evans CH; Wooley PH
Gene Ther; 2004 Mar; 11(5):483-91. PubMed ID: 14724688
[TBL] [Abstract][Full Text] [Related]
17. Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo.
Zhang X; Yu C; Xushi ; Zhang C; Tang T; Dai K
Biochem Biophys Res Commun; 2006 Mar; 341(1):202-8. PubMed ID: 16413501
[TBL] [Abstract][Full Text] [Related]
18. [Construction and identification of recombinant retroviral vector containing human interleukin 1 receptor antagonist and its expression in osteoarthritic human articular chondrocytes].
Rui Y; Wang Y; Zhang X; Sun H; Qu Z; Dai K
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 May; 22(5):533-8. PubMed ID: 18630429
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for osteoarthritis: new perspectives for the twenty-first century.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S262-72. PubMed ID: 11039780
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for osteoporosis: evaluation in a murine ovariectomy model.
Baltzer AW; Whalen JD; Wooley P; Latterman C; Truchan LM; Robbins PD; Evans CH
Gene Ther; 2001 Dec; 8(23):1770-6. PubMed ID: 11803396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
